Agios Pharmaceuticals, Inc. · NASDAQ:AGIO
D. E. Shaw & Co., L.P. reported a 6.50% stake in Agios Pharmaceuticals, Inc. (Schedule 13G/A)
Event Sep 30, 2026 · Filed Nov 16, 2026
D. E. Shaw & Co., L.P. reported a 6.50% stake in Agios Pharmaceuticals, Inc., 3,888,907 shares, as a passive investor on Sep 30, 2026. Filed Nov 16, 2026 (Schedule 13G/A).
- Stake
- 6.50%
- Shares
- 3,888,907
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| D. E. Shaw & Co., L.P. | 6.50% | 3,888,907 |
| David E. Shaw | 6.50% | 3,888,907 |
Source
Download original · View original at SEC
Related
- Agios Pharmaceuticals, Inc.
- D. E. Shaw & Co., L.P.
- Agios Pharmaceuticals, Inc. shareholders
- Schedule 13G · D. E. Shaw & Co., L.P. · Jul 2, 2026
- Schedule 13G/A · Lynx1 Capital Management LP · Nov 16, 2026
- Schedule 13G · Morgan Stanley · Nov 13, 2026
- Form 4 · Gheuens Sarah · Oct 28, 2026
- Form 4 · Gheuens Sarah · Oct 23, 2026
- Form 4 · Gheuens Sarah · Aug 6, 2026